Atlas Trials

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Clinical trial NCT01129713 · UNKNOWN

Trial details

NCT number
NCT01129713
Sponsor
Effexus Pharmaceutical
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease (GERD)HeartburnIndigestion
Start date
2010-05-01
Primary completion
2015-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.